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Abstract
Background: Genetic fusion of the major birch pollen allergen (Bet v1) to bacterial surface-(S)-layer proteins
resulted in recombinant proteins exhibiting reduced allergenicity as well as immunomodulatory capacity. Thus, S-
layer/allergen fusion proteins were considered as suitable carriers for new immunotherapeutical vaccines for
treatment of Type I hypersensitivity. Up to now, endotoxin contamination of the fusion protein which occurred
after isolation from the gram-negative expression host E. coli had to be removed by an expensive and time
consuming procedure. In the present study, in order to achieve expression of pyrogen-free, recombinant S-layer/
allergen fusion protein and to study the secretion of a protein capable to self-assemble, the S-layer/allergen fusion
protein rSbpA/Bet v1 was produced in the gram-positive organism Bacillus subtilis 1012.
Results: The chimaeric gene encoding the S-layer protein SbpA of Lysinibacillus sphaericus CCM 2177 as well as Bet v1
was cloned and expressed in B. subtilis 1012. For that purpose, the E. coli-B. subtilis shuttle vectors pHT01 for expression
in the B. subtilis cytoplasm and pHT43 for secretion of the recombinant fusion protein into the culture medium were
used. As shown by western blot analysis, immediately after induction of expression, B. subtilis 1012 was able to secret
rSbpA/Bet v1 mediated by the signal peptide amyQ of Bacillus amyloliquefaciens. Electron microscopical investigation of
the culture medium revealed that the secreted fusion protein was able to form self-assembly products in suspension
but did not recrystallize on the surface of the B. subtilis cells. The specific binding mechanism between the N-terminus
of the S-layer protein and a secondary cell wall polymer (SCWP), located in the peptidoglycan-containing sacculi of Ly.
sphaericus CCM 2177, could be used for isolation and purification of the secreted fusion protein from the culture
medium. Immune reactivity of rSbpA/Bet v1 could be demonstrated in immunoblotting experiments with Bet v1
specific IgE containing serum samples from patients suffering birch pollen allergy.
Conclusions: The impact of this study can be seen in the usage of a gram-positive organism for the production of
pyrogen-free self-assembling recombinant S-layer/allergen fusion protein with great relevance for the development
of vaccines for immunotherapy of atopic allergy.
Background
S-layers are crystalline arrays of proteinaceous subunits
representing the outermost cell envelope component in
many bacteria and most archaea [1-3]. One of the most
remarkable properties of isolated S-layer proteins is
their capability to self-assemble in suspension as flat
sheets or cylinders, into monomolecular protein lattices
on artificial surfaces (e. g. silicon wafers, noble metals,
plastics) or on Langmuir lipid films and liposomes [4-6].
S-layer proteins from Bacillaceae specifically recognize a
distinct type of secondary cell wall polymer (SCWP) as
the proper anchoring structure in the rigid cell wall
layer [7-10]. The SCWP of Ly. sphaericus CCM 2177
consists of disaccharide repeating units that are com-
posed of N-acetyl glucosamine (GlcNAc) and N-acetyl
mannosamine (ManNAc). The ManNAc residues carry
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a negative net charge [7]. In previous studies, isolated S-
layer-specific SCWP was also used as biomimetic linker
for the oriented recrystallization of recombinant S-layer
fusion proteins incorporating foreign functional
sequences, such as antigens, antibodies, ligands, or
enzymes on solid supports [5,6].
Due to the intrinsic adjuvant ability of S-layers as well
as their capability to display proteins and epitopes on
their surface, S-layers are excellent candidates to be
used as antigen carriers [11]. Specific immunotherapy
(SIT), a method consisting of the consecutive injection
of increasing doses of specific allergen to induce specific
tolerance in the allergic patient, represent the only cau-
sative treatment for Type I allergy [12]. Attempts to
improve vaccines for SIT focused on the allergic mole-
c u l e sa sw e l la so na d j u v a n t st h a ts u p p o r tt h es h i f to f
the Th2-based immune response toward a more
balanced phenotype [13]. For this purpose, in recent stu-
dies, the gene sequence encoding the major birch pollen
allergen Bet v1, was fused with the genes encoding the
S-layer protein of Geobacillus stearothermophilus ATCC
12980 or Lysinibacillus sphaericus CCM 2177 resulting
in the recombinant fusion proteins rSbsC/Bet v1 or
rSbpA/Bet v1, respectively [14,15]. Both S-layer/allergen
fusion proteins contained all relevant Bet v1-specific B
and T cell epitopes, but were significantly less efficient
to release histamine than rBet v1 [13,16,17]. Further
immunological studies showed that both fusion proteins
displayed strongly reduced IgE binding capacity than
free rBet v1 and promoted the induction of allergen-spe-
cific Th0/1 cells and regulatory T cells [13,16,17].
Derived from these results, both recombinant S-layer/
allergen fusion proteins can be considered as promising
candidates for the development of vaccines for specific
immunotherapy of Type I allergies.
In previous studies, gram-negative E. coli was used for
heterologous expression of rSbsC/Bet v1 or rSbpA/Bet
v1, respectively. Moreover, a very material and time
consuming purification procedure was performed to
remove endotoxin which was associated with the iso-
lated S-layer/allergen fusion proteins [14,15]. In immu-
nological applications, the presence of small amounts of
endotoxins, also called lipopolysaccharides (LPS), co-
purified with recombinant protein can cause fever, tissue
injury, endotoxin shock syndrome or the activation of
non-specific immune response in macrophages or B
cells [18]. Due to the fact that endotoxin removal tech-
niques belong to the most difficult tasks in downstream
processes during protein purification, the establishment
of a gram-positive endotoxin-free expression system for
S-layer/allergen fusion proteins was required.
T h ec h o i c eo fa na p p r o p r i a t eh o s ta n ds u i t a b l ep r o -
duction conditions is crucial for the downstream
processing of a pharmaceutical-grade product [19]. In
contrast to the gram-negative E. coli, B. subtilis is con-
sidered as a GRAS (generally recognized as safe) organ-
ism [20]. The reason for the usage of B. subtilis as cell
factory for the production of proteins with biotechnolo-
gical application potential, are a) its ability to secrete
functional extracellular proteins directly to the culture
medium and b) the accumulation of information con-
cerning its transcription and translation mechanisms,
genetic manipulation and large scale fermentation which
has been acquired during the last years [21]. A further
advantage for expression of recombinant S-layer/allergen
fusion proteins can be seen in the fact that B. subtilis
strains carry no S-layer on their cell surface.
In the present study, the strain B. subtilis 1012, a non-
pathogenic organism with naturally high secretory capa-
city was used as host for expression of the recombinant
S-layer/allergen fusion protein rSbpA/Bet v1. E. coli - B.
subtilis shuttle vectors pHT01, for intracellular expres-
sion, and pHT43, carrying the coding region for the sig-
nal peptide of the amyQ gene encoding a Bacillus
amyloliquefaciens a-amylase fused to the Shine-Dal-
garno sequence for extracelluar expression, were chosen.
Results
Construction of E. coli-B. subtilis shuttle vectors pHT01
and pHT43 carrying the chimaeric gene encoding the S-
layer/allergen fusion protein rSbpA/Bet v1 as well as
transformation of B. subtilis 1012
The E. coli-B. subtilis shuttle vectors pHT01 and pHT43
allow expression of recombinant proteins within the
cytoplasm, where pHT43 directs the target protein into
the medium. Both vectors are based on the s
A-depen-
dent promoter preceding the groE operon of B. subtilis
which has been converted into an IPTG-inducible pro-
moter by addition of the lac operator. For construction
of the B. subtilis expression vectors, the chimaeric gene
sbpA/bet v1 was cloned into the cloning sites AatII and
SmaI of plasmid pHT01 or pHT43, respectively.
For transformation, B. subtilis 1012 was grown under
vigorous shaking in HS medium at 37°C and the growth
curve was recorded (Figure 1A). After 5 h 15 min at an
optical density of 5, the culture reached the early sta-
tionary phase. From a cultivation time of 4 h 15 min to
6 h 15 min, aliquots were taken at 15-min intervals and
stored at -80°C. For estimation of the aliquots yielding
high level competent cells, one aliquot from each point
in time was checked by transformation with the refer-
ence plasmid pHT43. B. subtilis 1012 developed compe-
tence in the period from 5 h 15 min to 6 h of
cultivation (Figure 1A, grey column). In Figure 1B, the
transformation competence of B. subtilis 1012 at differ-
ent growth rates is shown. As estimated by counting of
colonies on selective plates containing chloramphenicol,
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using aliquots taken after 6 h of cultivation at an optical
density of 5.2 (Figure 1B). For transformation with the
plasmids pHT01/sbpA/bet v1 or pHT43/sbpA/bet v1,
respectively, B. subtilis 1012 cryo cultures of maximal
competence were used and positive B. subtilis transfor-
mants were detected on selective LB plates containing
chloramphenicol.
Intracellular and extracellular expression of the S-layer/
allergen fusion protein rSbpA/Bet v1 by B. subtilis 1012
and immunoblot analysis
To study the expression as well as the secretion of
rSbpA/Bet v1 by B. subtilis 1012 harbouring plasmid
pHT43/sbpA/bet v1, samples of SDS-extracted whole
cells and culture supernatants were taken before and 1
h, 2 h, and 3 h after induction of expression and exam-
ined by SDS-PAGE (Figure 2A). Immunoblot analysis
using a polyclonal antiserum raised against the S-layer
protein SbpA confirmed the occurrence of the SbpA
portion in the fusion protein in the cell pellet (Figure
2A, lane, 3-5) as well as in the supernatant (Figure 2A,
lanes 7-9) by a protein band migrating at 127.5 kDa. As
shown in Figure 2A, lanes 11 and 13, immunoblots
performed with the monoclonal antibody BIP1 raised
against Bet v1 detected the Bet v1 portion in the protein
band with the size of 127.5 kDa on the SDS gel. Recom-
binant rSbpA/Bet v1 derived from expression in E. coli
produced in a former study [15] and subjected to SDS-
PAGE as a positive control showed a protein band of
127.5 kDa (Figure 2A, lane 1). In samples taken before
induction of expression, no protein band could be
detected by using anti SbpA-antiserum (Figure 2A, lane
2 and 6) or BIP1 antibody (Figure 2A, lanes 10 and 12).
The intensity of the detected protein bands revealed
that, after induction of expression in B. subtilis 1012
carrying pHT43/sbpA/bet v1, the main part of the fusion
protein was secreted into the culture medium. A faint
protein band migrating at 127.5 kDa could be detected
in cell pellets of B. subtilis 1012 (Figure 2A, lanes 3-5
and lane 11). Electron microscopical investigation of
thin sections of B. subtilis 1012 cells harvested 3 h after
induction of rsbpA/bet v1 expression showed no S-layer
self-assembly products in the cell cytoplasm (data not
shown).
Investigation of intracellular expression of rSbpA/Bet
v1 by B. subtilis 1012 carrying pHT01/sbpA/bet v1 done
by immunoblotting of SDS-extracted cell pellets with
anti-SbpA antiserum (Figure 2B, lanes 2-4) or BIP1 (Fig-
ure 2B, lane 6) showed only a faint protein band of
127.5 kDa. Extension of expression time until over night
did not result in higher yield of rSbpA/Bet v1 (data not
shown). No S-layer fusion protein could be found before
induction of expression (Figure 2B, lanes 1 and 5) or in
the culture supernatant (data not shown). By comparing
the growth curves of induced and non-induced B. subti-
lis cells carrying pHT43/sbpA/bet v1 and pHT01/sbpA/
bet v1, respectively, it could be demonstrated that
expression of rSbpA/Bet v1 did not affect growth of B.
subtilis (data not shown).
TEM analysis of B. subtilis 1012 cells after expression and
secretion of the S-layer/allergen fusion protein
rSbpA/Bet v1
Three hours after induction of expression, an aliquot of
the B. subtilis cell culture carrying plasmid pHT43/
sbpA/bet v1 was harvested and subjected to negative
staining. Electron microscopical investigation showed
that the secreted S-layer/allergen fusion protein did not
recrystallize on the cell surface of B. subtilis 1012, how-
ever, in the culture medium, mono- and double layered
rSbpA/Bet v1 self-assembly products could be identified
(Figure 3A). Ultrastructural investigation of the self-
assembly products revealed a size of up to 1 μma n da
square S-layer lattice symmetry with a center-to-center
spacing of the subunits of 13.1 nm (Figure 3B). These
results indicated that the amount of fusion protein
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Figure 1 Estimation of the point in time for development of
maximal natural competence of B. subtilis 1012. A) Growth
curve of B. subtilis 1012 which was grown under vigorous shaking at
37°C in HS medium at 37°C. After 5 h 15 min at an optical density
of 5, the culture reached the early stationary phase. From a
cultivation time of 4 h 15 min to 6 h 15 min, aliquots were taken at
15-min time intervals. Transformation of aliquots from each point in
time with the reference plasmid pHT43 showed that B. subtilis
developed natural compentence in the period from 5 h 15 min to 6
h of cultivation (grey column). B) Estimation of transformation
competence of B. subtilis 1012 at different growth phases. After
transformation with plasmid pHT43, the number of colonies on
selective plates containing chloramphenicol revealed that maximal
transformation rates could be obtained by using aliquots taken after
6 h of cultivation at an optical density of 5.2.
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SDS-gel (Figure 2A, lanes 3-5) is not located in the cell
cytoplasm of the host cell. As derived from TEM analy-
sis, the protein band can be attributed to secreted and
assembled rSbpA/Bet v1 which was co-sedimented with
B. subtilis cells by centrifugation.
Recrystallization of the S-layer/allergen fusion protein on
solid supports, immunogold-labelling and electron
microscopical investigation
To isolate and concentrate the amount of secreted soluble
rSbpA/Bet v1 fusion protein from the B. subtilis culture
supernatant, the high specific binding mechanism between
the conserved S-layer homology (SLH) domain at the N-
terminus of the S-layer protein and the negatively charged
secondary cell wall polymer in the rigid cell wall layer of
Ly. sphaericus CCM 2177 was exploited. For that purpose,
the wild-type S-layer protein SbpA was completely
extracted from the surface of cell wall fragments of Ly.
sphaericus CCM 2177 by incubation with a chaotropic
agent. Three hours after induction of rsbpA/bet v1 expres-
sion, the obtained plain peptidoglycan-containing sacculi
of Ly. sphaericus CCM 2177 (Figure 4A) were added to an
aliquot of the B. subtilis 1012/pHT43/sbpA/bet v1 culture
Figure 2 Intra- and extracelluar expression of the S-layer/allergen fusion protein rSbpA/Bet v1 by B. subtilis 1012. (A) Extracellular
expression. Immunoblot analysis using the polyclonal rabbit antiserum raised against the S-layer protein SbpA. Purified S-layer fusion protein
rSbpA/Bet v1 isolated from E. coli BL21Star(DE3) used as positive control (lane 1), SDS-extracted whole cells of B. subtilis 1012 containing plasmid
pHT43/sbpA/bet v1 before (lane 2) and 1 h, 2 h and 3 h after induction of fusion protein expression (lane 3, 4 and 5). Supernatant fraction of the
B. subtilis 1012 cell culture before (lane 6) and 1 h, 2 h, 3 h after induction of expression (lane 7, 8 and 9). Immunoblot analysis using the
monoclonal antibody BIP1 raised against Bet v1. SDS-extracted whole cells of B. subtilis 1012 containing plasmid pHT43/sbpA/bet v1 before (lane
10) and 2 h after induction of fusion protein expression (lane 11). Supernatant fraction of the B. subtilis 1012 cell culture before (lane 12) and 2 h
after induction of expression (lane 13). WC: whole cells, SN: supernatant (B) Intracellular expression. Immunoblot analysis using the polyclonal
rabbit antiserum raised against the S-layer protein SbpA. SDS-extracted whole cells of B. subtilis 1012 containing plasmid pHT01/sbpA/bet v1
before (lane 1) and 1, 2, 3 h after induction of fusion protein expression (lane 2, 3 and 4). Immunoblot analysis using the monoclonal antibody
BIP1 raised against Bet v1. SDS-extracted whole cells of B. subtilis 1012 containing plasmid pHT01/sbpA/bet v1 before (lane 5) and 2 h after
induction of fusion protein expression (lane 6).
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The mixture was adjusted to 10 mM CaCl2 because pre-
vious studies revealed that the recrystallization process of
the S-layer protein SbpA is dependent on the presence of
calcium ions allowing control over lattice formation.
Negative staining and electron microscopical investigation
revealed small patches of recrystallized fusion protein on
the surface of the solid support (Figure 4B). To accumu-
late the S-layer fusion protein on the sacculi, the incuba-
tion procedure was repeated several times (Figure 4C).
Finally, peptidoglycan-containing sacculi completely cov-
ered with recrystallized S-layer/allergen fusion protein
clearly exhibiting the square lattice symmetry could be
obtained (Figure 4D).
For immunogold-labelling of the crystalline monolayer
formed by oriented recrystallization of rSbpA/Bet v1 on
peptidoglycan-containing sacculi of Ly. sphaericus CCM
2177, the recrystallization products were incubated with
monoclonal mouse antibody BIP1 which was visualized
by an anti-mouse IgG colloidal gold conjugate. As
shown in Figure 5, TEM analysis revealed that the sur-
face of the recrystallization products was completely
covered with gold particles (5 nm) except small areas
where no fusion protein could be found. These results
indicated that the Bet v1 portion was located on the
outer surface of the S-layer lattice. If samples of rSbpA
which were taken as negative control were recrystallized
on sacculi of Ly. sphaericus CCM 2177, no gold label-
ling could be observed in negatively stained preparations
(data not shown).
Quantification of the amount of purified rSbpA/Bet v1
after extracelluar expression by B. subtilis 1012
For quantification of expression, recrystallization pro-
ducts consisting of rSbpA/Bet v1 (derived from 20 ml
culture supernatant) recrystallized on 1 mg peptidogly-
can-containing sacculi of Ly. sphaericus CCM 2177 were
incubated with 2 ml of a chaotrophic agent. After
separation of the fusion protein rSbpA/Bet v1 from the
peptidoglycan-containing sacculi by centrifugation, the
supernatant was dialyzed against distilled water and 10
μl were subjected to SDS-PAGE analysis (Figure 6, lane
2). Furthermore, 10 μlo fa1m g / m ls t o c ks o l u t i o n( 1 0
μg) of rSbpA/Bet v1 purified from E. coli was also sub-
jected to the SDS-PAGE and used as a reference (Figure
6, lane 1). Derived from these data, quantification of the
protein concentration of purified rSbpA/Bet v1 after
extracelluar expression by B. subtilis 1012 revealed a
protein amount of ~ 50 mg per liter expression
medium.
Figure 3 Electron micrograph of a negatively stained preparation of B. subtilis 1012 cells carrying plasmid pHT43/sbpA/bet v1, 3h
after induction of rsbpA/bet v1 expression. (A) After secretion into the culture medium, the heterologously produced S-layer/allergen fusion
protein did not recrystallize on the cell surface of B. subtilis 1012 but was able to form self-assembly products with a maximum size of 1 μm
which clearly exhibited the square S-layer lattice symmetry. Bar = 100 nm (B) Detailed view on the ultrastructure of the rSbpA/Bet v1 self-
assembly products which show a center-to-center spacing of the morphological unit of 13.1 nm. Bar = 50 nm.
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immunoblots
The functionality of the Bet v1 domain in the fusion
protein was demonstrated by binding of IgE to rSbpA/
Bet v1 monomers spotted on a nitrocellulose membrane.
A ss h o w ni nad o tb l o ta s s a y ,I g Ef r o mas e r u ms a m p l e
of patients suffering atopic allergy caused by birch pol-
len recognized rSbpA/Bet v1 (Figure 7B) and showed a
comparable reaction to the positive control, for which
rBet v1 was taken (Figure 7A). Recombinant SbpA used
Figure 4 Electron micrograph of negatively stained preparations describing concentration and purification of the S-layer/allergen
fusion protein rSbpA/Bet v1 from B. subtilis culture medium by recrystallization on solid supports. (A) Peptidoglycan-containing sacculus
of Ly. sphaericus CCM 2177 without S-layer lattice. Bar = 100 nm (B) Peptidoglycan-containing sacculus of Ly. sphaericus CCM 2177 after first
incubation with B. subtilis 1012 culture medium containing secreted rSbpA/Bet v1 monomers. A patch of recrystallized rSbpA/Bet v1 on the
surface exhibiting the square lattice structure is clearly visible. Bar = 100 nm (C) Peptidoglycan-containing sacculus of Ly. sphaericus CCM 2177
after repeated incubation with B. subtilis 1012 culture medium containing secreted rSbpA/Bet v1 monomers. Bar = 100 nm (D) The ultrastructure
of the closed rSbpA/Bet v1 monolayer on the solid support in detail. Bar = 50 nm.
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city (Figure 7C).
Biocompatibility tests for investigation of Limulus
amebocyte lyste (LAL) reactivity of rSbpA/Bet v1
expressed in B. subtilis 1012 compared to the S-layer/
allergen fusion protein expressed in E. coli
LAL reactivity of rSbpA/Bet v1 expressed in gram-posi-
tive B. subtilis 1012 was tested and compared to the
endotoxin contamination of the recombinant S-layer/
allergen fusion protein isolated from gram-negative E.
coli. LAL assays revealed a LPS value of 20 EU/ml for
rSbpA/Bet v1 after intracellular expression in E. coli, iso-
lation from the host cell and purification with gel per-
meation chromatography (GPC) as well as an endotoxin
value of 1-2 EU/ml after a second GPC purification step.
In contrast to these results, no endotoxin could be
detected in rSbpA/Bet v1 expressed by B. subtilis 1012
and secreted into the culture medium.
Figure 5 Immunogold labelling of rSbpA/Bet v1 recrystallized on a solid support. After production in B. subtilis 1012, the S-layer/allergen
fusion protein rSbpA/Bet v1 recrystallized on peptidoglycan-containing sacculi of Ly. sphaericus CCM 2177 was incubated with the monoclonal
mouse antibody BIP1 raised against Bet v1. Bound BIP1 was detected by using colloidal gold-labelled anti-mouse IgG. Bar = 100 nm.
Figure 6 Quantification of extracelluar expression of rSbpA/Bet
v1 by B. subtilis 1012. SDS-PAGE analysis of rSbpA/Bet v1 (10 μg)
purified from E. coli (lane 1) and of rSbpA/Bet v1 isolated from 1 mg
peptidoglycan-containing sacculi of Ly. sphaericus CCM 2177 after
incubation with 20 ml culture supernatant of a B. subtilis 1012
culture harvested 3 h after induction of expression (lane 2).
Figure 7 Dot blot assay indicating the IgE reactivity of rSbpA/
Bet v1 fusion protein. Results indicated that rSbpA/Bet v1 (B) and
rBet v1 (A) which was used as a positive control showed strong IgE
reactivity when incubated with Bet v1-specific serum samples of
birch pollen allergic patients. Recombinant SbpA (C) used as a blank
did not show any reactivity.
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Because of their temperature and pH stability, the
removal of bacterial endotoxins becomes more difficult
when associated with labile biomolecules, such as pro-
teins [22]. Besides commonly used techniques like for
example ultrafiltration [23] and ion exchange chromato-
graphy [24], affinity chromatography is reported as an
effective method to reduce endotoxin in solutions [25].
Ultrafiltration can be useful to remove endotoxin aggre-
gates [22] but with large proteins like rSbpA/Bet v1
with a molecular weight of 127.5 kDa, used in this
study, this method is not effective. Due to the fact, that
S-layers are insoluble in buffers usually taken for affinity
chromatography, this technique turned out to be unsui-
table for endotoxin removal from S-layer preparations.
To achieve complete solubilization of S-layer proteins
into their constituent subunits, the addition of high con-
centrated hydrogen-bond-breaking agents (e. g. urea,
guanidinium hydrochloride) is required [5,6,26].
In recent years, various studies revealed that non-
pathogenic gram-positive B. subtilis is an attractive host
organism for the expression and secretion of heterolo-
gous proteins [19,21,27]. The advantage of secretion of
the target protein can be seen in a natural separation of
the product from cell components simplifying down-
stream processing as well as in the provision of better
refolding conditions compared to the reducing condi-
tions in the cell cytoplasm [19].
In the present study, with the aim to produce an endo-
toxin-free S-layer/allergen fusion protein, a gram-positive
expression system was developed based on the expression
host B. subtilis 1012 as well as the E. coli-B. subtilis shut-
tle vectors pHT01 or pHT43 carrying the amyQ signal
sequence. To estimate the point in time for development
of maximal natural competence, the growth curve of B.
subtilis 1012 was recorded and culture aliquots of esti-
mated maximal competence were used for transforma-
tion with the plasmids carrying a chimaeric gene
encoding rSbpA/Bet v1. In the case of B. subtilis 1012
cells carrying pHT43/sbpA/bet v1,c o m p a r i s o no ft h e
amount of rSbpA/Bet v1 in whole cells and in the super-
natant by SDS-PAGE revealed that the main part of the
produced fusion protein was secreted into the culture
medium from the beginning to the end of the stationary
growth phase. From these results, it can be concluded
that the signal peptide of the B. subtilis a-amylase works
well for S-layer fusion proteins and the high molecular
weight of the target protein did not interfere with the
secretion process. Additionally, it could be demonstrated
that the growth rate of B. subtilis was not affected by the
induction of rsbpA/bet v1 expression.
In [28], Howorka and co-workers reported the self-
assembly formation of SbsA, the S-layer protein of G.
stearothermophilus PV72/p6 in the course of autolysis
after expression in B. subtilis. This expression system
based on the xylose-inducible multicopy plasmid pSTR5
carrying the sbsA gene as well as the signal peptide of
the S-layer protein SbsA showed high level intracellular
expression but rSbsA was retained in the B. subtilis pep-
tidoglycan layer and therefore was poorly secreted into
the ambient cellular environment. In former studies
concerning the heterologous expression in E. coli,i t
could be demonstrated that the recombinant S-layer
proteins SbsA of G. stearothermophilus PV72/p6, SbsB
of G. stearothermophilus P V 7 2 / p 2o rS b s Cf r o mG.
stearothermophilus ATCC 12980, respectively, formed
self-assembly products in the cell cytoplasm directly
after expression [29-31]. In contrast to these results,
recombinant SbpA as well as the rSbpA/Bet v1 fusion
protein did not recrystallize in the E. coli cell cytoplasm
[15]. In view of the desired secretion of the SbpA/aller-
gen fusion protein after expression in B. subtilis,i nt h e
present study, this fact turned out to be an advantage.
A ss h o w nb ye l e c t r o nm i c r o s c opical investigation of
thin sections of B. subtilis 1012 cells harvested 3h after
induction of expression, no rSbpA/Bet v1 self-assembly
products were visible in the cell cytoplasm of the host
cells. Nearly 80% of rSbpA/Bet v1 secreted into the cul-
ture medium were soluble but electron microscopical
investigation of B. subtilis culture samples taken 3 h
after induction revealed that up to 20% of secreted
fusion protein formed self-assembly products. According
to results obtained by [28], no rSbpA/Bet v1 S-layer lat-
tice could be observed on the cell surface of B. subtilis.
However, for B. subtilis cells containing plasmid
pHT01/sbpA/bet v1, just a weak intracellular expression
of fusion protein could be observed. In order to increase
the yield of expression, it could be conducive to replace
the B. subtilis Pgrac promoter by one of the native sbpA
promoters identified in the upstream region of the sbpA
gene of Ly. sphaericus CCM 2177 in future studies[15].
Secreted rSbpA/Bet v1 could be concentrated by
exploiting the specific interaction between the conserved
N-terminus of SbpA in the fusion protein and a nega-
tively charged pyruvylated SCWP which is located in the
peptidoglycan-containing layer of Ly. sphaericus CCM
2177. In accordance to former studies performed with
the S-layer/allergen fusion protein isolated from E. coli
[14,15], rSbpA/Bet v1 expressed and secreted by B. sub-
tilis 1012 showed excellent recrystallization properties in
suspension and on solid supports. By immunoblotting,
the binding capacity of purified rSbpA/Bet v1 for IgE
from serum samples of birch pollen allergic patients
could be demonstrated.
Conclusions
In the present study for the first time, a pyrogen-free
recombinant S-layer/allergen fusion protein required for
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tive expression system based on B. subtilis 1012. The
usage of an E. coli-B. subtilis shuttle vector carrying the
sequence encoding the signal peptide of B. subtilis a-
amylase confers on the gram-positive organism the abil-
ity to secrete the expressed S-layer/allergen fusion pro-
tein rSbpA/Bet v1 directly into the culture medium.
Structural and immunological investigations of the
obtained fusion protein revealed that rSbpA/Bet v1 was
endotoxin-free, showed excellent recrystallization prop-
erties and immune reactivity.
Methods
Bacterial strains, plasmids and oligonucleotide primers
Bacterial strains, plasmids and oligonucleotides used in
this study were listed in Table 1.
Cloning of the chimaeric gene encoding rSbpA/Bet v1 in
pHT01 and in pHT43
For amplification of the gene encoding the S-layer/aller-
g e nf u s i o np r o t e i nr S b p A / B e tv 1( d e v o i do ft h e
sequence encoding the SbpA signal peptide), the plas-
mid pET28a (Invitrogen) carrying the chimaeric gene
sbpA/bet v1 derived from a previous study [15] was iso-
lated from E. coli TG1 and used as template. PCR
amplifications were performed as described in [32]. The
oligonucleotide primer SbpA/AatII/forward as well as
the primer Bet v1/SmaI/reverse (all listed in Table 1)
introduced the cloning sites AatII and SmaIa tt h e5 ’
and 3’-end, respectively. General procedures for DNA
manipulations were carried out as reported by [33].
Cloning of pHT01 (MoBiTec) and pHT43 (MoBiTec)
carrying the gene encoding rSbpA/Bet v1 in E. coli TG1
(Stratagene) was done as described in [32]. For selection
of positive transformants, the constructs were grown in
3 ml Luria-Broth Base medium (Invitrogen) at 37°C and
carbenicillin (Fluka) was added to a final concentration
of 50 μg / m l .F i n a l l y ,p l a s m i d sp H T 0 1 / sbpA/bet v1 and
pHT43/sbpA/bet v1 were re-isolated from E. coli TG1
by using QIAprep Spin Miniprep Kit (Qiagen) and
stored at -20°C. The correct construction of the vectors
was confirmed by sequencing.
Preparation of competent B. subtilis 1012 cells
B. subtilis 1012 (CatchMaps BV) was grown overnight at
37°C in a test tube on 5 ml HS medium (66.5 ml A. dest.,
10 ml 10 × S-base (Spizizen’s salt), 2.5 ml 20% (w/v) glu-
cose, 5 ml 0.1% (w/v) L-tryptophan, 1 ml 2% (w/v) casein,
5 ml 10% (w/v) yeast extract (Difco), 10 ml 8% (w/v) argi-
nine, 0.4% histidine) under shaking at 200 rpm. Subse-
quently, 0.5 ml of the overnight culture were diluted in
50 ml HS medium in a 500-ml flask, incubated under
shaking at 200 rpm at 37°C and the growth curve was
recorded. When cells reached the stationary growth
phase, samples of 10 ml were taken at 15-min time inter-
vals. Each aliquot was mixed with 1 ml 87% glycerol and
incubated for 15 min on ice. After fractionating into 1-ml
aliquots, all samples were frozen in liquid nitrogen and
stored at -80°C. For estimation of the aliquots yielding
high level competent cells, one aliquot from each point
in time was checked by transformation with a reference
plasmid pHT43 (MoBiTec) without insert.
Table 1 Bacterial strains, plasmids and oligonucleodide primers used in this study
Description Contents Reference/source
Strains
E. coli TG1 supE thi-1 Δ(lac-proAB) Δ(mcrB-hsdSM)5(rK- mK-) [F’ traD36 proAB lacIqZΔM15 Stratagene
B. subtilis 1012 leuA8, metB5, hsrM1, nonA CatchMaps BV,
MoBiTec
Plasmids
pET28a/sbpA/
bet v1
Cloning of rsbpA/bet v1 [15]
pHT01 Amp
r,C m
r,P grac promoter (consisting of groEpromotor, the lacO operator and the gsiBSD sequence, ColE1
ori,, lacI repressor, E. coli/B. subtilis shuttle vector
MoBiTec
pHT43 see pHT01 + amyQ signal sequence MoBiTec
pHT01/sbpA/
bet v1
Expression of rSbpA/Bet v1 in cytoplasm of B. subtilis 1012 This study
pHT43/sbpA/
bet v1
Expression of rSbpA/Bet v1 in cytoplasm of B. subtilis 1012 followed by subsequent secretion into the culture
medium
This study
Primers*
SbpA/AatII/
forward
5’-cgcgacgtcgcgcaagtaaacgactataacaaatc-3’ This study
Bet v1/SmaI/
reverse
5’-tcccccgggttagttgtaggcatcggagtgtg-3’ This study
*Bold nucleotide sequences indicate restriction endonuclease sites.
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For transformation of B. subtilis 1012, the slightly modi-
fied protocol of [34] was used. Cryo cultures of compe-
tent B. subtilis 1012 cells were thawed at 37°C, one
aliquot (1 ml) was used to inoculate 20 ml HS medium
and the culture was shaken at 200 rpm in a 30°C-water
bath for 2 h. Aliquots of 1 ml were put into a glass
tube, 10 μl of 0.1 M EGTA, pH 7.2 were added and the
mixture was incubated for 5 min at room temperature.
Plasmid DNA (3 μg) pHT01/sbpA/bet v1 or pHT43/
sbpA/bet v1, respectively, was added and the sample was
incubated for 2 h at 37°C while shaking at 200 rpm. For
detection of positive B. subtilis transformants, cells were
plated on selective LB plates containing chlorampheni-
col at a final concentration of 10 μg/ml.
Expression of the S-layer/allergen fusion protein in B.
subtilis 1012, preparation of cellular and supernatant
fractions and immunoblot analysis
B. subtilis 1012 cells carrying the plasmids pHT01/sbpA/
bet v1 or pHT43/sbpA/bet v1, respectively, were grown
in 3 ml LB medium containing chloramphenicol at a final
concentration of 10 μg/ml in a test tube under shaking at
200 rpm at 37°C overnight. Subsequently, 25 ml LB med-
ium were inoculated with 250 μl of the culture (dilution
1:100) containing chloramphenicol at a final concentra-
tion of 10 μg/ml and incubated under shaking at 200
rpm at 37°C. At an optical density of 2 at 600 nm, expres-
sion of rSbpA/Bet v1 was induced by addition of IPTG at
a final concentration of 1 mM. Samples (1.5 ml) of each
B. subtilis 1012 culture were taken before as well as 1 h,
2 h, 3 h and 18 h after induction of expression of rSbpA/
Bet v1. The supernatant and cellular fractions were sepa-
rated by centrifugation at 20,000 × g for 30 min at 4°C.
Cell pellets were incubated with lysozyme (final concen-
tration 1 mg/ml) for 5 min at 37°C before addition of
Laemmli buffer [35]. Preparation of samples for SDS-
PAGE analysis was carried out as described by [35].
Immunoblotting with a polyclonal rabbit antiserum raised
against the S-layer protein SbpA of Ly. sphaericus CCM
2177 was performed as described previously [15]. The
monoclonal mouse anti-Bet v1 antibody BIP1 was used to
check to presence of Bet v1 epitopes in the fusion protein
rSbpA/Bet v1 expressed in B. subtilis 1012 as well as in the
fusion protein rSbpA/Bet v1 expressed in E. coli (derived
from a former study [15]), which was used as a positive
control. For that purpose, after separation of the proteins
on SDS gels and blotting to a nitrocellulose membrane
(Potran; Schleicher and Schüll), blocking with 0.2% (Block-
ing Reagent CA AppliChem, Germany) in Tris-buffered sal-
ine solution (0.1 M TBS, pH 7.2) was applied for 18 h at 4°
C. The membrane was then incubated with BIP1 (diluted
1:100 in blocking solution) for 1.5 h at room temperature
and washed three times with wash solution (0.1 M TBS
containing 0.5% Tween20) and once with 0.1 M TBS. Sub-
sequently, the membrane was incubated with anti-mouse
IgG alkaline phosphatase conjugate (Sigma; diluted 1:5,000
in blocking solution) for 1 h at room temperature. After
washing steps as described above, bound antibody was
detected by incubation with 5-bromo-4-chloro-3-indolyl
phosphate and nitro blue tetrazolium chloride (BCIP/NBT;
Roche) as precipitating chromogenic substrate.
Electron microscopical investigation of B. subtilis 1012
cells after expression and secretion of the S-layer/allergen
fusion protein
For electron microscopical examination of B. subtilis 1012
cells containing pHT43/sbpA/bet v1 harvested 3 h after
induction of expression, 30 μl of cell culture were trans-
ferred onto a 300-mesh Formvar-coated copper grid
which was stabilized by vacuum deposition of carbon and
rendered hydrophilic by glow discharge [36]. For chemical
fixation of the sample, the grid was floated on a drop of
2.5% glutaraldehyde in 0.1 M sodium cacodylate buffer,
pH 7.0 for 15 min at room temperature. After 3 washing
steps with distilled water, negative staining was done by
incubation of the grid on a drop of 1% uranyl acetate for 5
min at room temperature [36]. Fixation, embedding as
well as ultrathin-sectioning of B. subtilis 1012 cells har-
vested 3 h after induction of rsbpA/bet v1 expression was
performed as described in a previous study. Electron
micrographs were taken with a Philips CM12 transmission
electron microscope (Philips Eindhoven, The Netherlands)
operated at 80 kV in low-dose mode [15].
Peparation of peptidoglycan-containing sacculi of Ly.
sphaericus CCM 2177
Ly. sphaericus CCM 2177 (Czech Collection of Microor-
ganism, Brno, Czech Republic) was grown in continuous
culture in nutrient broth medium at 30°C at a dilution
rate of 0.16 h
-1 as described in a previous study [7]. Pre-
paration of cell wall fragments of Ly. sphaericus CCM
2177 was done according to [37]. For preparation of
peptidoglycan-containing sacculi, cell wall fragments of
Ly. sphaericus CCM 2177 were incubated twice with 5
M guanidine hydrochloride (GHCl) in 50 mM Tris/HCl,
pH 7.2 for 20 min at 4°C for complete removal of the
wild-type S-layer protein SbpA. Subsequently, the
remaining peptidoglycan pellet was washed four times
with 50 mM Tris/HCl, pH 7.2, suspended in 15 ml of
distilled water, frozen at -20°C, and lyophilized.
Purification and concentration of the fusion protein
rSbpA/Bet v1 by recrystallization on solid supports,
immunogold-labelling and investigation by electron
microscopy
For isolation and concentration of the secreted fusion
protein rSbpA/Bet v1, 3 h after induction of expression,
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sphaericus CCM 2177 were added to a 5-ml aliquot of
the B. subtilis 1012/pHT43/sbpA/bet v1 culture superna-
tant. To induce the recrystallization process of the
fusion protein on the surface, the mixture was adjusted
to 10 mM CaCl2 and incubated by shaking at 4°C over-
night. Subsequently, the suspension was centrifuged at
20,000 × g at 4°C for 10 min and the pellet was incu-
bated again with a new 5-ml aliquot of supernatant of
the B. subtilis 1012/pHT43/sbpA/bet v1 culture. The
procedure was repeated 2 times and the pellet contain-
ing recrystallization products was subsequently applied
for negative staining and electron microscopical investi-
gation performed as described above.
Immunogold-labelling was done by incubation of the
samples with monoclonal mouse antibody BIP1 raised
against Bet v1 for 2 h at room temperature. After centri-
fugation of the suspension at 16,000 × g for 10 min at
4°C and 3 washing steps with 0.15 M TBS buffer, the pel-
let was suspended in 30 μl anti-mouse IgG-colloidal gold
(Sigma) and incubated for 60 min at room temperature.
Unbound gold-labelled antibody was removed by centri-
fugation under conditions described above and three
washing steps with 0.15 M TBS buffer. The pellet was
resuspended in 20 μl distilled water and subjected to
negative staining. As a control, the whole procedure was
also performed by using recrystallization products con-
sisting of rSbpA (recombinantly produced in E. coli in a
previous study [15] which was recrystallized on peptido-
glycan-containing sacculi of Ly. sphaericus CCM 2177.
Quantification of the amount of purified rSbpA/Bet v1
after extracelluar expression by B. subtilis 1012
For quantification of expression, recrystallization pro-
ducts (produced as described above) consisting of
rSbpA/Bet v1 (derived from 20 ml culture supernatant)
recrystallized on 1 mg peptidoglycan-containing sacculi
of Ly. sphaericus CCM 2177 were incubated with 2 ml
of 5 M GHCl in 50 mM Tris/HCl, pH 7.2 for 10 min at
4°C. The fusion protein rSbpA/Bet v1 was separated
from the peptidoglycan-containing sacculi of Ly. sphaer-
icus CCM 2177 by centrifugation of the samples at
14,000 rpm for 15 min at 4°C. The supernatant was dia-
lyzed against distilled water for 16 h at 4°C and 10 μl
were subjected to SDS-PAGE analysis. To estimate the
concentration of the fusion protein in the dialyzed
supernatant, 10 μlo fa1m g / m ls t o c ks o l u t i o n( 1 0μg)
of rSbpA/Bet v1 purified from E. coli was also subjected
to the SDS-PAGE and used as a reference.
Immuno dot blot for detection of IgE reactivity of rSbpA/Bet
v1 by with serum samples from birch pollen allergic patients
For investigation of IgE reactivity, rSbpA/Bet v1 fusion
protein as well as rSbpA acting as blank and rBet v1
used as positive control (both proteins derived from
[15]) were spotted onto a nitrocellulose membrane
which was subsequently incubated with sera from
patients suffering from birch pollen allergy at 4°C for 16
h. The procedure was followed by incubation with
monoclonal anti-human IgE alkaline phosphatase conju-
gate (Sigma; diluted 1:6,000) and detection with BCIP/
NBT was done as described above.
Biocompatibility test for investigation of LAL reactivity of
rSbpA/Bet v1 expressed in B. subtilis 1012
Detection and quantification of gram-negative bacterial
endotoxins of 100 μl culture medium containing rSbpA/
Bet v1 secreted by B. subtilis 1012 during 3 h of expression
was performed following the manufacturer’s instructions
(Limulus Amebocyte Lysate, PYROCHROME
®, U.S.).
Results were compared with those obtained from LAL-
tests carried out with rSbpA/Bet v1 which was expressed
in E. coli BL21Star(DE3) (Invitrogen) and purified as
described in a former study [15].
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